Neurol. praxi. 2023;24(2):132-139 | DOI: 10.36290/neu.2022.062

Covid-19 and its impact on (chronic) pain - observations from experience

MUDr. Jan Procházka, Ph.D.
Centrum léčby chronické bolesti, Klinika anesteziologie, perioperační a intenzivní medicíny UJEP, KZ, a. s., Masarykova nemocnice, Ústí nad Labem

Pain is a common symptom accompanying the coronavirus disease COVID-19 caused by coronavirus SARS-CoV-2. In addition to acute headache, myalgia and arthralgia or neuropathic pain in context of acute viral illness, chronic pain can be worsened as well. This can be due to post-viral syndrome, direct affection of nervous system by viral penetration, or as a consequence of psychological distress due to limited health care, social isolation, fear of infection and so on. When proceeding of the interventional procedures in patients with COVID-19 disease we should take general precautions for personal protection and consider a dose of corticoids and undergoing anticoagulation therapy. We can anticipate a higher incidence of chronic fatigue syndrome in patients with COVID-19. We found 82 patients with chronic pain of locomotive systems in our clinical praxis who suffered Covid-19, 23% with severe form and 77% light to moderate form of Covid-19. A similar worsening of chronic pain was reported in 68% cases in both groups, whilst the same degree of chronic pain was reported in 32% cases.

Keywords: COVID-19 pandemic, chronic pain, psychological distress, chronic fatigue syndrome, fibromyalgia.

Received: September 15, 2022; Revised: October 3, 2022; Accepted: October 12, 2022; Prepublished online: October 12, 2022; Published: April 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Procházka J. Covid-19 and its impact on (chronic) pain - observations from experience. Neurol. praxi. 2023;24(2):132-139. doi: 10.36290/neu.2022.062.
Download citation

References

  1. Abbi B, Natelson BH. Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the "single syndrome" hypothesis. Q J Med. 2013;106:3-9. Go to original source...
  2. Alizadeh R, Aghsaeifard Z. Does COVID19 activates previous chronic pain? A case series. Ann Med Surg. 2021;61:169-171 Go to original source...
  3. Carrillo­‑de­‑la­‑Pena MT, González­‑Villar A, Trinanes Y. Effects of the COVID-19 pandemic on chronic pain in Spain: a scoping review. Pain Rep. 2021;6:e899. Go to original source... Go to PubMed...
  4. Clauw DJ, Häuser W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020; 161(8): 1694-97. Go to original source... Go to PubMed...
  5. Covid Portál: https://covid.gov.cz/situace/informace­‑o-vakcine/informace­‑o-dostupnych­‑vakcinach.
  6. Fallon N, Brown C, Twiddy H, et al. Adverse effects of COVID-19 - related lockdown on pain, physical aktivity and psychological well­‑being in people with chronic pain. Brit J Pain. 2020; doi: 10.1177/2049463720973703. Go to original source... Go to PubMed...
  7. Guadarrama­‑Ortiz P, Choreno­‑Parra JA, Sánchez­‑Martínez CM, et al. Neurological aspects of SARS­‑CoV-2 infection: mechanisms and manifestations. Front Neurol. 2020;11:1039. Go to original source...
  8. Hascalovici J, Shaparin N. The other side of the COVID-19 curve: a model for the safe reintegration of elective interventional pain procedures. Pain Phys. 2020;23:S449-S451. Go to original source...
  9. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-32. Go to original source...
  10. Kaur A, Singh L, Singh N, et al. Ameliorative effect of imperatorin in chemically induced fibromyalia: Role of NMDA/NFkB mediated downstream signaling. Biochem Pharmacol. 2019;166:56-69. Go to original source...
  11. Kemp HL, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Brit J Anaesth. 2020;125(4): 436-40. Go to original source... Go to PubMed...
  12. Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encefalomyelitis/chronic fatigue syndrome? Front Med. 2021;7:606824. Go to original source...
  13. Lacasse A, Pagé MG, Dassieu L, et al. Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatment of pain: findings from the Chronic pain & COVID-19 Pan­‑Canadian Study. Pain Rep. 2021_6_e891. Go to original source...
  14. Lopez­‑Leon S, Wegman­‑Ostrosky T, Perelman C, et al. More than 50 long­‑term effects of COVID-19: a systematic review and meta­‑analysis. Sci Rep. 2021;11(1):16144. Go to original source... Go to PubMed...
  15. Meo SA, Bukhari IA, Akram J, et al. COVID-19 Vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. 2021;25:1663-69. Go to PubMed...
  16. Meyer­‑Friessem CH, Giertmühlen J, Baron R, et al. Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge. Pain Rep. 2021;6:e893. Go to original source...
  17. Mun CJ, Campbell CM, McGill LS, Aaron RV. The early impact of COVID-19 on chronic pain: A cross­‑sectional investigation of a large online sample of indiviuals with chronic pain in the United States, April to May, 2020. Pain Med. 2021;22(2):470-80. Go to original source... Go to PubMed...
  18. Murphy MT, Latif U. Pain during COVID-19: A comprehensive review and guide for the interventionalist. Pain Pract. 2021;21(1):132-43. Go to original source... Go to PubMed...
  19. Rýdlová J, Fabiánová J. Myalgická encefalomyelitida - praktická aplikace Mezinárodních konsenzuálních kritérií. Med praxi. 2013;10(4):160-62.
  20. Salaffi F, Giorgi V, Sirotti S, et al. The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol. 2020. PMID: 33200740. Go to original source...
  21. Serrano­‑Ibanez ER, Esteve R, Ramírez­‑Maestre C, et al. Chronic pain in the time of COVID-19: Stress aftermath and central senzitization. Brit J Health Psychol. 2020; doi: 10.1111/bjhp.12483. Go to original source... Go to PubMed...
  22. Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta­‑analysis. Front Immunol. 2021. doi: 10.3389/.fimmu.2021.714170. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.